MARGENZA
NDC 70720-022, margetuximab-cmkb, injection, solution, concentrate, from TerSera Therapeutics LLC.
- Product NDC
- 70720-022
- Status
- Listed
- Labeler
- TerSera Therapeutics LLC
- Dosage form
- INJECTION, SOLUTION, CONCENTRATE
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761150
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70720-022 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MARGETUXIMAB25 mg/mL
Pharmacologic classes
HER2/Neu/cerbB2 Antagonists [MoA]; HER2/neu Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/6a6d50c7-06ea-479c-83cc-f197a9e428c9
Use it
Look up 70720-022 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70720-022 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70720-022. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.